HLB Life Science Co., Ltd. (KOSDAQ:067630)

HLB Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 14, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	456,927	472,158	1,219,355	1,165,599	1,077,864	1,188,951
Market Cap Growth	-40.09%	-61.28%	4.61%	8.14%	-9.34%	-7.14%
Enterprise Value	603,797	602,001	1,270,943	1,260,366	1,030,778	1,020,209
Last Close Price	3750.00	3875.00	10010.00	11155.39	10327.26	11533.40
PE Ratio	-	-	198.66	-	-	-
PS Ratio	9.99	10.32	37.21	11.90	10.82	22.23
PB Ratio	1.53	1.59	3.06	5.04	4.57	4.82
P/TBV Ratio	1.86	1.92	3.45	6.66	7.52	6.48
EV/Sales Ratio	13.20	13.16	38.78	12.86	10.35	19.07
Debt / Equity Ratio	0.54	0.54	0.31	0.72	0.63	0.02
Net Debt / Equity Ratio	0.49	0.49	0.11	0.38	0.07	-0.55
Net Debt / EBITDA Ratio	-9.28	-9.28	-3.14	-4.93	-1.05	8.54
Net Debt / FCF Ratio	-3.02	-3.02	-0.75	-2.86	-0.38	8.20
Asset Turnover	0.09	0.09	0.07	0.24	0.29	0.18
Inventory Turnover	7.21	7.21	6.40	12.26	16.27	30.72
Quick Ratio	0.26	0.26	1.86	0.68	5.50	11.28
Current Ratio	0.38	0.38	2.01	0.73	6.00	11.59
Return on Equity (ROE)	-28.68%	-28.68%	2.13%	-2.53%	-22.52%	-18.45%
Return on Assets (ROA)	-2.58%	-2.58%	-2.60%	-3.82%	-3.65%	-3.83%
Return on Invested Capital (ROIC)	-4.94%	-4.74%	-5.24%	-8.94%	-11.00%	-14.52%
Return on Capital Employed (ROCE)	-5.90%	-5.90%	-4.10%	-8.90%	-5.20%	-7.10%
Earnings Yield	-21.84%	-21.14%	0.50%	-0.51%	-5.04%	-4.13%
FCF Yield	-10.62%	-10.27%	-4.86%	-2.63%	-3.75%	-1.39%
Buyback Yield / Dilution	-9.19%	-9.19%	-9.65%	-0.80%	-1.64%	-0.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.